LINC00707 inhibits myocardial fibrosis and immune disorder in rheumatic heart disease by regulating miR-145-5p/S1PR1

References

• Bill, M., Papaioannou, D., Karunasiri, M., Kohlschmidt, J., Pepe, F., Walker, C., Walker, A., Brannan, Z., Pathmanathan, A., Zhang, X., Mrózek, K., LaRocco, A., Volinia, S., Bloomfield, C., Garzon, R., & Dorrance, A. J. L. (2019). Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells. Leukemia, 33(9), 2169–2182. https://doi.org/10.1038/s41375-019-0429-5
   PubMed Web of Science ®Google Scholar
• Chen, J., Li, X., Zhao, F., & Hu, Y. J. C. I. I. A. (2021). Hotair/miR-17-5p axis is involved in the propofol-mediated cardioprotection against ischemia/reperfusion injury. Clinical Interventions in Aging, 16, 621–632. https://doi.org/10.2147/cia.S286429
   PubMed Web of Science ®Google Scholar
• Chen, A., Wen, J., Lu, C., Lin, B., Xian, S., Huang, F., Wu, Y., & Zeng, Z. (2020). Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease. International Journal of Molecular Medicine, 45(2), 429–440. https://doi.org/10.3892/ijmm.2019.4420
   PubMed Web of Science ®Google Scholar
• Dooley, L., Ahmad, T., Pandey, M., Good, M., & Kotiw, M. (2021). Rheumatic heart disease: A review of the current status of global research activity. Journal of Autoimmunity Reviews, 20(2), 102740. https://doi.org/10.1016/j.autrev.2020.102740
   PubMed Web of Science ®Google Scholar
• Hou, J., Long, H., Zhou, C., Zheng, S., Wu, H., Guo, T., Wu, Q., Zhong, T., & Wang, T. (2017). Long noncoding RNA Braveheart promotes cardiogenic differentiation of mesenchymal stem cells in vitro. Stem Cell Research & Therapy, 8(1), 4. https://doi.org/10.1186/s13287-016-0454-5
   PubMed Web of Science ®Google Scholar
• Kou, Y., Zheng, W. T., & Zhang, Y. R. (2016). Inhibition of miR-23 protects myocardial function from ischemia-reperfusion injury through restoration of glutamine metabolism. European Review for Medical and Pharmacological Sciences, 20(20), 4286–4293.
   PubMed Web of Science ®Google Scholar
• Liu, H., & Liu, B. (2018). Inhibition of MicroRNA-23 contributes to the isoflurane-mediated cardioprotection against oxidative stress. Cardiovascular Toxicology, 18(5), 450–458. https://doi.org/10.1007/s12012-018-9455-1
   PubMed Web of Science ®Google Scholar
• Liu, J., Wu, M., Feng, G., Li, R., Wang, Y., Jiao, & Jiao, J. J. I. J. O. M. M. (2020). Downregulation of LINC00707 promotes osteogenic differentiation of human bone marrow‑derived mesenchymal stem cells by regulating DKK1 via targeting miR‑103a‑3p. 46 (3), 1029–1038. https://doi.org/10.3892/ijmm.2020.4672.
   Google Scholar
• Li, Z., Wang, H., Zeng, Q., Yan, J., Hu, Y., Li, H., & Yu, Z. (2020). P65/MiR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma. Cancer Medicine, 9(2), 711–723. https://doi.org/10.1002/cam4.2611
   PubMed Web of Science ®Google Scholar
• Papait, R., Kunderfranco, P., Stirparo, G., Latronico, M., & Condorelli, G. (2013). Long noncoding RNA: A new player of heart failure? Journal of Cardiovascular Translational Research, 6(6), 876–883. https://doi.org/10.1007/s12265-013-9488-6
   PubMed Web of Science ®Google Scholar
• Piccoli, M. T., Gupta, S. K., Viereck, J., Foinquinos, A., Samolovac, S., Kramer, F. L., Garg, A., Remke, J., Zimmer, K., Batkai, S., & Thum, T. (2017). Inhibition of the cardiac fibroblast–Enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction. Circulation Research, 121(5), 575–583. https://doi.org/10.1161/circresaha.117.310624
   PubMed Web of Science ®Google Scholar
• Rwebembera, J., Beaton, A., de Loizaga, S., Rocha, R., Doreen, N., Ssinabulya, I., Okello, E., Fraga, C., Galdino, B., Nunes, M., & Nascimento, B. (2021). The global impact of rheumatic heart disease. Current Cardiology Reports, 23(11), 160. https://doi.org/10.1007/s11886-021-01592-2
   PubMed Web of Science ®Google Scholar
• Sun, M., Liu, X., Wei, W., Ge, N., Luo, S., Shen, S., & Ge, R. (2022). BAP31 promotes proliferation, invasion, and metastasis of liver cancer cells via activating PI3K/AKT pathway. Journal of Healthcare Engineering, 2022, 7686728. https://doi.org/10.1155/2022/7686728
   PubMed Web of Science ®Google Scholar
• Sun, L., Zhu, W., Zhao, P., Wang, Q., Fan, B., Zhu, Y., Lu, Y., Chen, Q., Zhang, J., & Zhang, F. J. C. D. (2020). & disease. Cell Death & Disease, 11(8), 696. https://doi.org/10.1038/s41419-020-02783-5
   PubMed Web of Science ®Google Scholar
• Wang, K., Liu, F., Zhou, L. Y., Long, B., Yuan, S. M., Wang, Y., Liu, C. Y., Sun, T., Zhang, X. J., & Li, P. F. (2014). The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circulation Research, 114(9), 1377–1388. https://doi.org/10.1161/circresaha.114.302476
   PubMed Web of Science ®Google Scholar
• Wang, J., & Zhao, Q. (2020). LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α. International Immunopharmacology, 84, 106497. https://doi.org/10.1016/j.intimp.2020.106497
   PubMed Web of Science ®Google Scholar
• Wen, Y., Zeng, Z., Gui, C., Li, L., & Li, W. J. C. P. T. O. J. O. T. S. F. C. P. (2015). Changes in the expression of Th17 cell-associated cytokines in the development of rheumatic heart disease. Cardiovascular Pathology, 24(6), 382–387. https://doi.org/10.1016/j.carpath.2015.07.006
   PubMed Web of Science ®Google Scholar
• Wu, W., Guo, L., Liang, Z., Liu, Y., & Yao, Z. J. J. O. C. (2020). Lnc-SNHG16/miR-128 axis modulates malignant phenotype through WNT/β-catenin pathway in cervical cancer cells. Biotechnic & Histochemistry, 11(8), 2201–2212. https://doi.org/10.7150/jca.40319
   Web of Science ®Google Scholar
• Wu, X., Zeng, Z., Gong, D., Wen, J., Huang, F. J. B., & Commission, H. O. P. O. T. B. S. (2019). Potential involvement of S1PR1/STAT3 signaling pathway in cardiac valve damage due to rheumatic heart disease. Biotechnic & Histochemistry, 94(6), 398–403. https://doi.org/10.1080/10520295.2019.1574028
   PubMed Web of Science ®Google Scholar
• Xian, S., Chen, A., Wu, Y., Wen, H., Lu, C., Huang, F., & Zeng, Z. (2021). Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease. International Journal of Molecular Medicine, 48(3), 179. https://doi.org/10.3892/ijmm.2021.5012
   PubMed Web of Science ®Google Scholar
• Xin, Q., Li, J., Dang, J., Bian, X., Shan, S., Yuan, J., Qian, Y., Liu, Z., Liu, G., Yuan, Q., Liu, N., Ma, X., Gao, F., Gong, Y., & Liu, Q. (2015). MiR-155 deficiency ameliorates autoimmune inflammation of systemic lupus erythematosus by targeting S1pr1 in Faslpr/lpr Mice. Journal of Immunology, 194(11), 5437–5445. https://doi.org/10.4049/jimmunol.1403028
   PubMed Web of Science ®Google Scholar
• Zhang, J., Liu, H., Liu, J., Zhang, Y., Liu, J., & Li, Y. (2021). LncRNA AL592284.1 facilitates proliferation and metastasis of cervical cancer cells via miR-30a-5p/Vimentin/EMT axis. Biochemical Biophysical Research Communications, 577, 95–102. https://doi.org/10.1016/j.bbrc.2021.09.014
   PubMed Web of Science ®Google Scholar
• Zhu, S., Zhou, Z., Li, Z., Shao, J., Jiao, G., Huang, Y., & Lin, Y. J. B. (2019). Biotechnology, & biochemistry. Bioscience, Biotechnology, and Biochemistry, 83(11), 2049–2056. https://doi.org/10.1080/09168451.2019.1637245
   PubMed Web of Science ®Google Scholar